Mechanism of metabolic stroke and spontaneous cerebral hemorrhage in glutaric aciduria type I

Acta Neuropathologica Communications

Volumn 2, Issue 1, 2014, Pages

  Zinnanti, William J ^a   Lazovic, Jelena ^b   Housman, Cathy ^c   Antonetti, David A ^d   Koeller, David M ^e   Connor, James R ^c   Steinman, Lawrence ^a  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Blood brain barrier; Cerebral hemorrhage; Glutaric aciduria; Metabolic stroke

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTARYL COENZYME A DEHYDROGENASE; OCCLUDIN;

ANIMAL; BRAIN; C57BL MOUSE; CAPILLARY; CEREBRAL HEMORRHAGE; COMPLICATION; DEFICIENCY; DISEASE MODEL; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; ELECTRON MICROSCOPY; GENETICS; MAGNETIC RESONANCE ANGIOGRAPHY; METABOLIC ENCEPHALOPATHY; METABOLISM; MOUSE; NONPARAMETRIC TEST; PATHOLOGY; STROKE; TRANSGENIC MOUSE; ULTRASTRUCTURE;

AMINO ACID METABOLISM, INBORN ERRORS; ANIMALS; BRAIN; BRAIN DISEASES, METABOLIC; CAPILLARIES; CEREBRAL HEMORRHAGE; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTARYL-COA DEHYDROGENASE; MAGNETIC RESONANCE ANGIOGRAPHY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; OCCLUDIN; STATISTICS, NONPARAMETRIC; STROKE;

EID: 84901767053     PISSN: None     EISSN: 20515960     Source Type: Journal    
DOI: 10.1186/2051-5960-2-13     Document Type: Article

References (52)

1. Sutherland GR, Auer RN: Primary intracerebral hemorrhage. J Clin Neurosci 2006, 13(5):511-517. doi: 10.1016/j.jocn.2004.12.012 10.1016/j.jocn.2004.12.012
2. Barber PA, Auer RN, Buchan AM, Sutherland GR: Understanding and managing ischemic stroke. Can J Physiol Pharmacol 2001, 79(3):283-296. 10.1139/y00-125
3. Schreiber J, Chapman KA, Summar ML, Ah Mew N, Sutton VR, MacLeod E, Stagni K, Ueda K, Franks J, Island E, Matern D, Pena L, Smith B, Urv T, Venditti C, Chakarapani A, Gropman AL: Neurologic considerations in propionic acidemia. Mol Genet Metab 105(1):10-15. doi: 10.1016/j.ymgme.2011.10.003
4. Strauss KA, Lazovic J, Wintermark M, Morton DH: Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency. Brain 2007, 130(Pt 7):1905-1920. doi: 10.1093/brain/awm058
5. Hoffmann GF, Gibson KM, Trefz FK, Nyhan WL, Bremer HJ, Rating D: Neurological manifestations of organic acid disorders. Eur J Pediatr 1994, 153(7 Suppl 1):S94-S100.
6. Dave P, Curless RG, Steinman L: Cerebellar hemorrhage complicating methylmalonic and propionic acidemia. Arch Neurol 1984, 41(12):1293-1296. 10.1001/archneur.1984.04050230079025
7. Woelfle J, Kreft B, Emons D, Haverkamp F: Subdural hemorrhage as an initial sign of glutaric aciduria type 1: a diagnostic pitfall. Pediatr Radiol 1996, 26(11):779-781. 10.1007/BF01396200
8. Hartley LM, Mrcp B, Khwaja OS, Verity CM, Frcpch B: Glutaric aciduria type 1 and nonaccidental head injury. Pediatrics 2001, 107(1):174-175. 10.1542/peds.107.1.174
9. Kolker S, Garbade SF, Greenberg CR, Leonard JV, Saudubray JM, Ribes A, Kalkanoglu HS, Lund AM, Merinero B, Wajner M, Troncoso M, Williams M, Walter JH, Campistol J, Marti-Herrero M, Caswill M, Burlina AB, Lagler F, Maier EM, Schwahn B, Tokatli A, Dursun A, Coskun T, Chalmers RA, Koeller DM, Zschocke J, Christensen E, Burgard P, Hoffmann GF: Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 2006, 59(6):840-847. 10.1203/01.pdr.0000219387.79887.86
10. Strauss KA, Puffenberger EG, Robinson DL, Morton DH: Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C: Semin Med Genet 2003, 121(1):38-52.
11. Goodman SI, Frerman FE: Organic Acidemias due to defects in lysine oxidation: 2-ketoadipic academia and glutaric academia. In The metabolic and molecular bases of inherited disease. 3rd edition. Edited by: Scriver C, Beudet A, Sly W, Valle D. New York: McGraw Hill; 1995:2195-2204.
12. Kyllerman M, Steen G: Glutaric aciduria. A "common" metabolic disorder? Arch Fr Pediatr 1980, 37(4):279.
13. Van Der Watt G, Owen EP, Berman P, Meldau S, Watermeyer N, Olpin SE, Manning NJ, Baumgarten I, Leisegang F, Henderson H: Glutaric aciduria type 1 in South Africa-high incidence of glutaryl-CoA dehydrogenase deficiency in black South Africans. Mol Genet Metab 101(2-3):178-182. doi: 10.1016/j.ymgme.2010.07.018
14. Haworth JC, Booth FA, Chudley AE, deGroot GW, Dilling LA, Goodman SI, Greenberg CR, Mallory CJ, McClarty BM, Seshia SS, Seargeant LE, et al.: Phenotypic variability in glutaric aciduria type I: Report of fourteen cases in five Canadian Indian kindreds. J Pediatr 1991, 118(1):52-58. 10.1016/S0022-3476(05)81843-8
15. Naughten ER, Mayne PD, Monavari AA, Goodman SI, Sulaiman G, Croke DT: Glutaric aciduria type I: outcome in the Republic of Ireland. J Inherit Metab Dis 2004, 27(6):917-920. doi: 10.1023/B:BOLI.0000045777.82784.74
16. Zinnanti WJ, Lazovic J, Wolpert EB, Antonetti DA, Smith MB, Connor JR, Woontner M, Goodman SI, Cheng KC: A diet-induced mouse model for glutaric aciduria type I. Brain 2006, 129(Pt 4):899-910.
17. Zinnanti WJ, Lazovic J, Housman C, LaNoue K, O'Callaghan JP, Simpson I, Woontner M, Goodman SI, Connor JR, Jacobs RE, Cheng KC: Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I. J Clin Invest 2007, 117(11):3258-3270. 10.1172/JCI31617
18. Koeller DM, Woontner M, Crnic LS, Kleinschmidt-DeMasters B, Stephens J, Hunt EL, Goodman SI: Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I. Hum Mol Genet 2002, 11(4):347-357. 10.1093/hmg/11.4.347
19. Benevenga NJ, Steele RD: Adverse effects of excessive consumption of amino acids. Annu Rev Nutr 1984, 4: 157-181. 10.1146/annurev.nu.04.070184.001105
20. Tsubuku S, Mochizuki M, Mawatari K, Smriga M, Kimura T: Thirteen-week oral toxicity study of L-lysine hydrochloride in rats. Int J Toxicol 2004, 23(2):113-118. 10.1080/10915810490444415
21. Franklin KBJ, Paxinos G: The mouse brain in steriotaxic coordinates. 2nd edition. San Diego, Ca: Academic Press, Inc.; 1997.
22. Blinder P, Shih AY, Rafie C, Kleinfeld D: Topological basis for the robust distribution of blood to rodent neocortex. Proc Natl Acad Sci USA 107(28):12670-12675. doi: 10.1073/pnas.1007239107
23. Del Bigio MR, Yan HJ, Kozlowski P, Sutherland GR, Peeling J: Serial magnetic resonance imaging of rat brain after induction of renal hypertension. Stroke 1999, 30(11):2440-2447. 10.1161/01.STR.30.11.2440
24. Sundstrom JM, Tash BR, Murakami T, Flanagan JM, Bewley MC, Stanley BA, Gonsar KB, Antonetti DA: Identification and analysis of occludin phosphosites: a combined mass spectrometry and bioinformatics approach. J Proteome Res 2009, 8(2):808-817. doi: 10.1021/pr7007913 10.1021/pr7007913
25. Osborn AG: Diagnostic neuroradiology [print]. 1st edition. St. Louis: Mosby; 1994.
26. Papapetropoulos S, Singer C, Sengun C, Gallo BV: Giant arteriovenous malformation presenting as pediatric task-specific dystonia. Neurology 2008, 70(15):1294. doi: 10.1212/01.wnl.0000306637.14628.76 10.1212/01.wnl.0000306637.14628.76
27. Ito U, Hakamata Y, Kawakami E, Oyanagi K: Temporary [corrected] cerebral ischemia results in swollen astrocytic end-feet that compress microvessels and lead to delayed [corrected] focal cortical infarction. J Cereb Blood Flow Metab 2011, 31(1):328-338. doi: 10.1038/jcbfm.2010.97 10.1038/jcbfm.2010.97
28. Strauss KA, Donnelly P, Wintermark M: Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency. Brain 2010, 133(Pt 1):76-92. doi: 10.1093/brain/awp297
29. Citi S, Cordenonsi M: Tight junction proteins. Biochim Biophys Acta 1998, 1448(1):1-11. 10.1016/S0167-4889(98)00125-6
30. Denker BM, Nigam SK: Molecular structure and assembly of the tight junction. Am J Physiol 1998, 274(1 Pt 2):F1-F9.
31. Murakami T, Felinski EA, Antonetti DA: Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem 2009, 284(31):21036-21046. doi: 10.1074/jbc. M109.016766 10.1074/jbc. M109.016766
32. Muhlhausen C, Ergun S, Strauss KA, Koeller DM, Crnic L, Woontner M, Goodman SI, Ullrich K, Braulke T: Vascular dysfunction as an additional pathomechanism in glutaric aciduria type I. J Inherit Metab Dis 2004, 27(6):829-834.
33. Jin KL, Mao XO, Nagayama T, Goldsmith PC, Greenberg DA: Induction of vascular endothelial growth factor and hypoxia-inducible factor-1alpha by global ischemia in rat brain. Neuroscience 2000, 99(3):577-585. 10.1016/S0306-4522(00)00207-4
34. Kilic T, Akakin A: Anatomy of cerebral veins and sinuses. Front Neurol Neurosci 2008, 23: 4-15. doi: 10.1159/0000111256
35. Muhlhausen C, Ott N, Chalajour F, Tilki D, Freudenberg F, Shahhossini M, Thiem J, Ullrich K, Braulke T, Ergun S: Endothelial effects of 3-hydroxyglutaric acid: implications for glutaric aciduria type I. Pediatr Res 2006, 59(2):196-202. doi: 10.1203/01.pdr.0000197313.44265.cb 10.1203/01.pdr.0000197313.44265.cb
36. Matsumoto K, Imagawa S, Obara N, Suzuki N, Takahashi S, Nagasawa T, Yamamoto M: 2-Oxoglutarate downregulates expression of vascular endothelial growth factor and erythropoietin through decreasing hypoxia-inducible factor-1alpha and inhibits angiogenesis. J Cell Physiol 2006, 209(2):333-340. doi: 10.1002/jcp.20733 10.1002/jcp.20733
37. Stokke O, Goodman SI, Moe PG: Inhibition of brain glutamate decarboxylase by glutarate, glutaconate, and beta-hydroxyglutarate: explanation of the symptoms in glutaric aciduria? Clin Chim Acta 1976, 66(3):411-415. 10.1016/0009-8981(76)90241-2
38. Strauss KA, Morton DH: Type I glutaric aciduria, part 2: a model of acute striatal necrosis. Am J Med Genet C: Semin Med Genet 2003, 121(1):53-70.
39. Hamilton RL, Haas RH, Nyhan WL, Powell HC, Grafe MR: Neuropathology of propionic acidemia: a report of two patients with basal ganglia lesions. J Child Neurol 1995, 10(1):25-30. 10.1177/088307389501000107
40. Al-Essa M, Bakheet S, Patay Z, Al-Watban J, Powe J, Joshi S, Ozand PT: Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in glutaric aciduria type 1: clinical and MRI correlations. Brain Dev 1998, 20(5):295-301. 10.1016/S0387-7604(98)00033-3
41. Baric I, Zschocke J, Christensen E, Duran M, Goodman SI, Leonard JV, Muller E, Morton DH, Superti-Furga A, Hoffmann GF: Diagnosis and management of glutaric aciduria type I. J Inherit Metab Dis 1998, 21(4):326-340. 10.1023/A:1005390105171
42. Harting I, Neumaier-Probst E, Seitz A, Maier EM, Assmann B, Baric I, Troncoso M, Muhlhausen C, Zschocke J, Boy NP, Hoffmann GF, Garbade SF, Kolker S: Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. Brain 2009, 132(Pt 7):1764-1782. doi: 1093/brain/awp112
43. Hamilton BF, Gould DH: Correlation of morphologic brain lesions with physiologic alterations and blood-brain barrier impairment in 3-nitropropionic acid toxicity in rats. Acta Neuropathol 1987, 74(1):67-74. 10.1007/BF00688340
44. Nishino H, Czurko A, Fukuda A, Hashitani T, Hida H, Karadi Z, Lenard L: Pathophysiological process after transient ischemia of the middle cerebral artery in the rat. Brain Res Bull 1994, 35(1):51-56. 10.1016/0361-9230(94)90215-1
45. Fu Y, He F, Zhang S, Huang J, Zhang J, Jiao X: 3-Nitropropionic acid produces indirect excitotoxic damage to rat striatum. Neurotoxicol Teratol 1995, 17(3):333-339. 10.1016/0892-0362(94)00076-P
46. Linden T, Kalimo H, Wieloch T: Protective effect of lesion to the glutamatergic cortico-striatal projections on the hypoglycemic nerve cell injury in rat striatum. Acta Neuropathol 1987, 74(4):335-344. 10.1007/BF00687210
47. McGeer EG, McGeer PL, Singh K: Kainate-induced degeneration of neostriatal neurons: dependency upon corticostriatal tract. Brain Res 1978, 139(2):381-383. 10.1016/0006-8993(78)90941-1
48. Nishino H, Czurko A, Onizuka K, Fukuda A, Hida H, Ungsuparkorn C, Kunimatsu M, Sasaki M, Karadi Z, Lenard L: Neuronal damage following transient cerebral ischemia and its restoration by neural transplant. Neurobiology (Bp) 1994, 2(3):223-234.
49. Hamilton BF, Gould DH: Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol (Berl) 1987, 72(3):286-297. 10.1007/BF00691103
50. Johnston MV, Trescher WH, Ishida A, Nakajima W: Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr Res 2001, 49(6):735-741. 10.1203/00006450-200106000-00003
51. Calabresi P, Centonze D, Gubellini P, Marfia GA, Pisani A, Sancesario G, Bernardi G: Synaptic transmission in the striatum: from plasticity to neurodegeneration. Prog Neurobiol 2000, 61(3):231-265. 10.1016/S0301-0082(99)00030-1
52. Antonetti DA, Wolpert EB, DeMaio L, Harhaj NS, Scaduto RC Jr: Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem 2002, 80(4):667-677. 10.1046/j.0022-3042.2001.00740.x